Scientists at the National Institute of Standards and Technology (NIST) have developed the first US standard for measuring the radioactivity of actinium-225, a radioactive isotope that drug companies are using to develop a new class of anticancer drugs. The new standard, which is tied to the International… Read More
Bayer and Bicycle Therapeutics have entered into a strategic collaboration agreement to discover, develop, manufacture, and commercialise Bicycle radioconjugates for multiple oncology targets. Bicyclic peptides are peptides consisting of 9-20 amino acids that can be synthetically manufactured and bind to targets with high affinity and selectivity,… Read More
Medicines Discovery Catapult (MDC) has relaunched radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) at the University of Manchester, UK. The facility, which was closed in 2020, includes the multi-million pound ‘Cyclotron’, one of only a few in the UK. It will supply radio-chemicals to drug discovery biotechs and academics,… Read More
